Journal of Clinical Endocrinology & Metabolism, Vol 73, 637-643, Copyright © 1991 by Endocrine Society

ARTICLES

Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow

AD Baron, M Laakso, G Brechtel and SV Edelman
Department of Medicine, Veterans Administration Medical Center, San Diego, California 92161.

To define the kinetic mechanisms of insulin resistance (IR) in insulin- dependent diabetes (IDDM), we studied seven control (C) and five IDDM (glycohemoglobin, 14 +/- 2+) men matched for age (36 +/- 2 vs. 37 +/- 3 yr), lean body mass (59 +/- 2 vs. 58 +/- 3 kg), and leg volume (mean +/- SEM, 10.4 +/- 0.3 vs. 9.8 +/- 0.5 L). Maximal capacity (Vmax) and affinity (Km) for glucose uptake in whole body (WBGU) and leg skeletal muscle (LGU) were measured during a 120 mU/m2.min insulin infusion, and blood glucose was clamped at about 4, 7, 12, and 21 mmol/L. LGU = femoral arterio-venous glucose difference (FAVGD) X leg blood flow (LBF). Compared to C, IDDMs had about 35% lower rates of WBGU at all glucose levels (P less than 0.01). The FAVGD (millimoles per L) in C vs. IDDM was 1.23 +/- 0.05 vs. 1.06 +/- 0.09, 2.44 +/- 0.11 vs. 2.24 +/- 0.16, 2.91 +/- 0.18 vs. 2.91 +/- 0.30, and 3.27 +/- 0.12 vs. 3.35 +/- 0.4 (P = NS at each glucose). LBF (decaliters per min) was reduced in IDDM vs. C [2.8 +/- 0.5 vs. 4.3 +/- 0.4 (P less than 0.05), 3.1 +/- 0.4 vs. 5.1 +/- 0.7 (P less than 0.05), 2.7 +/- 0.2 vs. 6.3 +/- 0.8 (P less than 0.01), and 3.1 +/- 0.7 vs. 6.5 +/- 0.8 (P less than 0.01) at each glucose level]. Kinetic analysis revealed that 1) the Vmax for WBGU and LGU were reduced in IDDM vs. C (P less than 0.05), and 2) the Vmax for skeletal muscle glucose extraction (FAVGD) was identical in C and IDDM (3.6 mmol/L). The Km values for WBGU, LGU, and glucose extraction were not different in C and IDDM (approximately 6 mmol/L). Thus, in IDDM 1) decreased glucose uptake is due to reduced skeletal muscle glucose uptake; 2) muscle glucose extraction is normal, but blood flow is reduced; and thus, 3) in IDDM, IR is due to reduced glucose and insulin delivery (blood flow) to skeletal muscle. This represents a novel mechanism for in vivo IR.

This article has been cited by other articles:

				J. D. Chiu, J. M. Richey, L. N. Harrison, E. Zuniga, C. M. Kolka, E. Kirkman, M. Ellmerer, and R. N. Bergman Direct Administration of Insulin Into Skeletal Muscle Reveals That the Transport of Insulin Across the Capillary Endothelium Limits the Time Course of Insulin to Activate Glucose Disposal Diabetes, April 1, 2008; 57(4): 828 - 835. [Abstract] [Full Text] [PDF]

				E. M. Eggleston, L. A. Jahn, and E. J. Barrett Hyperinsulinemia Rapidly Increases Human Muscle Microvascular Perfusion but Fails to Increase Muscle Insulin Clearance: Evidence That a Saturable Process Mediates Muscle Insulin Uptake Diabetes, December 1, 2007; 56(12): 2958 - 2963. [Abstract] [Full Text] [PDF]

				A. Basu, N. Charkoudian, W. Schrage, R. A. Rizza, R. Basu, and M. J. Joyner Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1289 - E1295. [Abstract] [Full Text] [PDF]

				R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]

				G. Li, E. J. Barrett, H. Wang, W. Chai, and Z. Liu Insulin at Physiological Concentrations Selectively Activates Insulin But Not Insulin-Like Growth Factor I (IGF-I) or Insulin/IGF-I Hybrid Receptors in Endothelial Cells Endocrinology, November 1, 2005; 146(11): 4690 - 4696. [Abstract] [Full Text] [PDF]

				A. P. Rocchini, J. Q. Yang, and A. Gokee Hypertension and Insulin Resistance Are Not Directly Related in Obese Dogs Hypertension, May 1, 2004; 43(5): 1011 - 1016. [Abstract] [Full Text] [PDF]

				M. Scheuermann-Freestone, P. L. Madsen, D. Manners, A. M. Blamire, R. E. Buckingham, P. Styles, G. K. Radda, S. Neubauer, and K. Clarke Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes Circulation, June 24, 2003; 107(24): 3040 - 3046. [Abstract] [Full Text] [PDF]

				M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan Blood flow and muscle metabolism: a focus on insulin action Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E241 - E258. [Abstract] [Full Text] [PDF]

				J. Sundell and J. Knuuti Insulin and myocardial blood flow Cardiovasc Res, February 1, 2003; 57(2): 312 - 319. [Abstract] [Full Text] [PDF]

				B. J. Behnke, C. A. Kindig, P. McDonough, D. C. Poole, and W. L. Sexton Dynamics of microvascular oxygen pressure during rest-contraction transition in skeletal muscle of diabetic rats Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H926 - H932. [Abstract] [Full Text] [PDF]

				M. Hamilton-Wessler, M. Ader, M. K. Dea, D. Moore, M. Loftager, J. Markussen, and R. N. Bergman Mode of Transcapillary Transport of Insulin and Insulin Analog NN304 in Dog Hindlimb: Evidence for Passive Diffusion Diabetes, March 1, 2002; 51(3): 574 - 582. [Abstract] [Full Text] [PDF]

				M.A. Vincent, D. Dawson, A.D.H. Clark, J.R. Lindner, S. Rattigan, M.G. Clark, and E.J. Barrett Skeletal Muscle Microvascular Recruitment by Physiological Hyperinsulinemia Precedes Increases in Total Blood Flow Diabetes, January 1, 2002; 51(1): 42 - 48. [Abstract] [Full Text] [PDF]

				D.W. Laight, M.J. Carrier, and E.E. Anggard Antioxidants, diabetes and endothelial dysfunction Cardiovasc Res, August 18, 2000; 47(3): 457 - 464. [Abstract] [Full Text] [PDF]

				A. P. Rocchini, H. Z. Mao, K. Babu, P. Marker, and A. J. Rocchini Clonidine Prevents Insulin Resistance and Hypertension in Obese Dogs Hypertension, January 1, 1999; 33(1): 548 - 553. [Abstract] [Full Text] [PDF]

				M. Pendergrass, E. Fazioni, D. Collins, and R. A. DeFronzo IGF-I increases forearm blood flow without increasing forearm glucose uptake Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E345 - E350. [Abstract] [Full Text] [PDF]

				R. C. Bonadonna, M. P. Saccomani, S. Del Prato, E. Bonora, R. A. DeFronzo, and C. Cobelli Role of Tissue-Specific Blood Flow and Tissue Recruitment in Insulin-Mediated Glucose Uptake of Human Skeletal Muscle Circulation, July 21, 1998; 98(3): 234 - 241. [Abstract] [Full Text] [PDF]

				A. Holmang, M. Muller, O. K. Andersson, and P. Lonnroth Minimal influence of blood flow on interstitial glucose and lactate-normal and insulin-resistant muscle Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E446 - E452. [Abstract] [Full Text] [PDF]

				J. Turinsky, A. Damrau-Abney, and D. J. Loegering Blood flow and glucose uptake in denervated, insulin-resistant muscles Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R311 - R317. [Abstract] [Full Text] [PDF]

				E. Duner, F. Di Virgilio, R. Trevisan, M. R. Cipollina, G. Crepaldi, and R. Nosadini 4Intracellular Free Calcium Abnormalities in Fibroblasts From Non–Insulin-Dependent Diabetic Patients With and Without Arterial Hypertension Hypertension, April 1, 1997; 29(4): 1007 - 1013. [Abstract] [Full Text]

				S. Makimattila, A. Virkamaki, P.-H. Groop, J. Cockcroft, T. Utriainen, J. Fagerudd, and H. Yki-Jarvinen Chronic Hyperglycemia Impairs Endothelial Function and Insulin Sensitivity Via Different Mechanisms in Insulin-Dependent Diabetes Mellitus Circulation, September 15, 1996; 94(6): 1276 - 1282. [Abstract] [Full Text]

				A. P. Rocchini, R. F. Wilson, P. Marker, and T. Cervenka Metabolic and Hemodynamic Effects of a Graded Intracoronary Insulin Infusion in Normal and Fat Anesthetized Dogs : A Preliminary Study Hypertension, March 1, 1996; 27(3): 354 - 359. [Abstract] [Full Text]

				P. Iozzo, P. Chareonthaitawee, M. Di Terlizzi, D. J. Betteridge, E. Ferrannini, and P. G. Camici Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1163 - E1171. [Abstract] [Full Text] [PDF]